Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: cardiovascular diseases

Yogurt enriched with a natural extract rich in PAF inhibitors and polyphenols. Study design and rationale of a randomized, double blinded, placebo-controlled, parallel intervention study

Maria Detopoulou, Tzortzis Nomikos, Elizabeth Fragopoulou, Mary Yannakoulia, Adamantini Kyriakou, Demosthenes Panagiotakos, Smaragdi Antonopoulou

Height as marker of cardiometabolic risk, a combined analysis of two cohorts

Konstantinos Christou Gkouvas, Alexandra Foscolou, Demosthenes Panagiotakos

No associations between dietary intake of polyunsaturated fatty acids and 10-year (2002-2012) cardiovascular disease risk, in relation to depressive symptomatology, the ATTICA study

Konstantina Katsana, Demosthenes Panagiotakos, Ekavi Georgousopoulou, George Soulis, Georgia-Maria Kouli, Natasa Kollia, Christina Chrysohoou, Dimitrios Tousoulis, Christodoulos Stefanadis, Christos Pitsavos

Relationship of obstractive sleep apnea with cardiovascular disease and the role of lifestyle habits in the management of the cardiometabolic complications of the disease

Ioanna Kechribari, Michael Georgoulis, Meropi Kontogianni, Emmanuel Vagiakis, Nikos Yiannakouris

Design of multifunctional molecules: a pharmacochemical approach applied to multifactorial diseases such as atherosclerosis

Alexios N. Matralis, Maria Katselou, Angeliki P. Kourounakis

Greek physician’s knowledge and viewpoints for the consumption of n-3 polyunsaturated fatty acids

Stefanos Tyrovolas, Eleutherios Topalidis, Lida Karaveli, Demosthenes Panagiotakos

CURRENT ISSUE

Empagliflozin in mice fed on a fast-food diet: Preliminary biochemical data
The role of epidemiology research in economic evaluation for Health Technology Assessment
Type 1 diabetes mellitus and cardiovascular risk: A short review
Health literacy in relation to health outcomes in hypertension: A systematic review
A Collection of Position Statements and Opinions on e-cigarette use and cardiovascular disease: On behalf of the Working Group on Epidemiology of the Hellenic Atherosclerosis Society

Keywords

acute coronary syndrome (4) Arterial hypertension (3) arterial stiffness (5) Atherosclerosis (19) blood pressure (3) cardiovascular disease (22) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (5) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (3) diabetes mellitus (9) diet (4) dyslipidemia (14) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (7) inflammation (9) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (7) metabolic syndrome (7) mortality (7) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (7) omega-3 fatty acids (3) outcome (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombosis (4) treatment (5) type 2 diabetes (3) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2023
A SiteOrigin Theme